arrow
M

Mitsuhiro Goda

Tokushima University
H指数:20
被引数:1,306

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adverse events of cetuximab sarotalocan in photoimmunotherapy: insights from the Japanese adverse drug event report database

西妥昔单抗索托洛坎在光免疫疗法中的不良反应:来自日本不良药物事件报告数据库的见解

2026-08-120
PRE
Muscle Atrophy-Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase Data

抗糖尿病药物类药物引起的肌肉萎缩相关不良事件:一项使用VigiBase数据的药物警戒分析

2026-04-140
OAAI
Bile Acids as Candidate Therapies for Multiple Sclerosis: Inverse Signal Analysis Using the FDA Adverse Event Reporting System and Preclinical Validation

胆汁酸作为多发性硬化候选疗法:使用FDA不良事件报告系统进行反向信号分析及临床前验证

2026-03-050
OAAI
Trends in the use of sodium-glucose cotransporter-2 inhibitors and characteristics of adverse event reporting in patients with heart failure in Japan: reports from the medical administration database and the adverse event reporting database

钠-葡萄糖协同转运蛋白-2抑制剂的使用趋势及日本心力衰竭患者不良反应报告的特征:来自医疗管理数据库和不良反应报告数据库的报告

2025-07-310
PRE
Flunitrazepam increases the risk of lamotrigine-induced cutaneous adverse reactions: Combined analysis of medical big data and clinical research

氟硝西泮增加拉莫三嗪诱导的皮肤不良反应风险:医疗大数据与临床研究的联合分析

2025-07-170
OAAI
Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world database

基于真实世界数据库识别 mogamulizumab 诱导的免疫相关不良事件的不良药物警戒研究

2025-07-010
OAAI
Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments
2024-10-010
OAAI